Relationship between the induction of inflammatory processes and infectious diseases in patients with ischemic stroke

Acta Biochimica Polonica

Volumn 60, Issue 3, 2013, Pages 345-349

  Cieślak, Marek ^a   Wojtczak, Andrzej ^b   Cieślak, Michał ^c  

^a Nerology Department   (Poland)

^b NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^c KAZIMIERZ WIELKI UNIVERSITY   (Poland)

Author keywords

Cytokines; Interleukin 1 receptor; Ischemic stroke

Indexed keywords

ANIMALIA;

ANTIINFLAMMATORY AGENT; HYDROCORTISONE; IL6 PROTEIN, HUMAN; IMMUNOLOGIC FACTOR; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

BRAIN ISCHEMIA; CELL MOTION; CEREBROVASCULAR ACCIDENT; COMMUNICABLE DISEASE; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMUNOLOGY; INFLAMMATION; MICROBIOLOGY; REVIEW; T LYMPHOCYTE;

ANTI-INFLAMMATORY AGENTS; BRAIN ISCHEMIA; CELL MOVEMENT; COMMUNICABLE DISEASES; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMMUNOLOGIC FACTORS; INFLAMMATION; INTERLEUKIN-1; INTERLEUKIN-6; PITUITARY-ADRENAL SYSTEM; RECEPTORS, INTERLEUKIN-1; STROKE; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84885900275     PISSN: 0001527X     EISSN: 1734154X     Source Type: Journal    
DOI: 10.18388/abp.2013_1991     Document Type: Review

References (44)

1. Astrup J, Siesjö BK, Symon L (1981) Thresholds in cerebral ischemia -the ischemic penumbra. Stroke 12:723-725.
2. Basic Kes VB, Simundic AM, Nicolac N et al. (2008) Pro-inflammatory and anti-inflammatory cytokines in acute ischemic stroke and their relation to early neurological deficit and stroke outcome. Clinical Biochemistry 41:1330-1334.
3. Becker KJ (1998) Inflammation and acute stroke. Curr Opin Neurol 11: 45-49.
4. Becker KJ (2001) Targeting the central nervous system inflammatory response in ischemic stroke. Curr Opin Neurol 14:349-353.
5. Benveniste E, Tang L, Law R (1995) Differential regulation of astrocyte TNF-alpha expression by the cytokines TGF-beta, IL-6 and IL-10. Int J Dev Neurosci 13:341-349.
6. Beridze M, Sanikidze T, Shakarishvili R et al. (2011) Selected acute phase CSF factors in ischemic stroke:findings and prognostic value. BMC Neurol 30:11-41.
7. Biber K, Pinto-Duarte A, Wittendrop MC (2008) Interleukin-6 upregulates neuronal adenosine A1 receptors:implications for neuromodulation and neuroprotection. Neuropsychopharmacology 33:2237-2250.
8. Boutin H, LeFeuvre RA, Horai R et al. (2001) Role of IL-1alpha and IL-1beta in ischemic brain damage. J Neurosci 1:5528-5534.
9. Clausen BH, Lambertsen KL, Babcock AA et al. (2008) Interleukin-1beta and tumor necrosis factor-alpha are expressed by different subsets of microglia and macrophages after ischemic stroke in mice. J Neuroinflammation 5:46.
10. Clausen BH, Lambertsen KL, Meldgaard M et al. (2005) Quantitative in situ hybridization and polymerase chain reaction study of microglialmacrophage expression of interleukin-1beta mRNA following permanent middle cerebral artery occlusion in mice. Neuroscience 132: 879-892.
11. Conroy SM, Nguyen V, Quina LA et al. (2004) Interleukin-6 produces neuronal loss in developing cerebellar granule neuron cultures. J Neuroimmunol 155:43-54.
12. Dziewulska D, Mossakowski MJ (2003) Cellular expression of tumor necrosis factor a and its receptors in human ischemic stroke. Clin Neuropathol 22:35-40.
13. Emsley HC, Smith CJ, Gavin CM et al. (2007) Clinical outcome following acute ischemic stroke relates to both activation and autoregulatory inhibition of cytokine production. BMC Neurol 28:7:5.
14. Emsley HC, Smith CJ, Georgiou RF, Vail A, Hopkins SJ, Rothwell NJ et al. (2005) A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients. J Neurol Neurosurg Psychiatry 76: 1366-1372.
15. Emsley HC, Smith CJ, Tyrrell PJ et al. (2008) Inflammation in acute ischemic stroke and its relevance to stroke critical care. Neurocrit Care 9:125-138.
16. Fassbender K, Rossol S, Kammer T et al. (1994) Proinflammatory cytokines in serum of patients with acute cerebral ischemia:kinetics of secretion and relation to the extent of brain damage and outcome of disease. J Neurol Sci 122:135-139.
17. Gertz K, Kronenberg G, Kälin RE, Baldinger T, Werner C, Balkaya M, Eom GD, Hellmann-Regen J, Kröber J, Miller KR, Lindauer U, Laufs U, Dirnagl U, Heppner FL, Endres M (2012) Essential role of interleukin-6 in post-stroke angiogenesis. Brain 135:1964-1980.
18. Kostulas N, Kivisäkk P, Huang Y, Matusevicius D, Kostulas V, Link H (1998) Ischemic stroke is associated with a systemic increase of blood mononuclear cells expressing interleukin-8 mRNA. Stroke 29: 462-466.
19. Lambertsen KL, Meldgaard M, Ladeby R et al. (2005) A quantitative study of microglial-macrophage synthesis of tumor necrosis factor during acute and late focal cerebral ischemia in mice. J Cereb Blood Flow Metab 25:119-135.
20. Licata G, Tuttolomondo A, Di Raimondo D, Corrao S, Di Sciacca R, Pinto A (2009) Immuno-inflammatory activation in acute cardioembolic strokes in comparison with other subtypes of ischaemic stroke. Thromb Haemost 101:929-937.
21. Maas MB, Furie KL (2009) Molecular biomarkers in stroke diagnosis and prognosis. Biomark Med 3:363-383.
22. Montaner J, Rovira A, Molina CA et al. (2003) Plasmatic level of neuroinflammatory markers predict the extent of diffusion-weighted image lesions in hyperacute stroke. J Cereb Blood Flow Metab 23: 1403-1407.
23. Nayak A, Kashyap R, Kabra D, Purohit H, Taori G, Daginawala H (2012) Time course of inflammatory cytokines in acute ischemic stroke patients and their relation to inter-alfa trypsin inhibitor heavy chain 4 and outcome. Ann Indian Acad Neurol 15:181-185.
24. Nayak A, Kashyap R, Purohit H, Kabra D, Taori G, Daginawala H (2009) Evaluation of the inflammatory response in sera from acute ischemic stroke patients by measurement of IL-2 and IL-10. Inflamm Res 58:687-691.
25. Nelson TE, Netzeband JG, Gruol DL (2004) Chronic interleukin-6 exposure alters metabotropic glutamate receptor-activated calcium signalling in cerebellar Purkinje neurons. Eur J Neurosci 20:2387-400.
26. Ormstad H, Aass HC, Lund-Sørensen N et al. (2011) Serum levels of cytokines and C-reactive protein in acute ischemic stroke patients, and their relationship to stroke lateralization, type, and infarct volume. J Neurol 258:677-685.
27. Pizzi M, Sarnico I, Boroni F et al. (2004) Prevention of neuron and oligodendrocyte degeneration by interleukin-6 (IL-6) and IL-6 receptor/ IL-6 fusion protein in organotypic hippocampal slices. Mol Cell Neurosci 25:301-311.
28. Rodriguez-Mercado R, Ford GD, Xu Z, Kraiselburd EN, Martinez MI, Eterovic VA, Colon E, Rodriguez IV, Portilla P, Ferchmin PA, Gierbolini L, Rodriguez-Carrasquillo M, Powell MD, Pulliam JV, McCraw CO, Gates A, Ford BD (2012) Acute neuronal injury and blood genomic profiles in a nonhuman primate model for ischemic stroke. Comp Med 62:427-438.
29. Sairanen T, Carpen O, Karjalainen-Lindsberg ML et al. (2001) Evolution of cerebral tumor necrosis factor-alpha production during human ischemic stroke. Stroke 32:1750-1758.
30. Singh HV, Pandey A, Shrivastava AK, Raizada A, Singh SK, Singh N (2013) Prognostic value of neuron specific enolase and IL-10 in ischemic stroke and its correlation with degree of neurological deficit. Clin Chim Acta 18:419:136-138.
31. Smith C, Emsley H, Udeh Ch et al. (2012) Interleukin-1 receptor antagonist reverses stroke-associated peripheral immune suppression. Cytokine 58:384-389.
32. Smith CJ, Emsley HC, Gavin CM, Georgiou RF, Vail A, Barberan EM, del Zoppo GJ, Hallenbeck JM, Rothwell NJ, Hopkins SJ, Tyrrell PJ (2004) Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol 15:4:2.
33. Sun Y, Lu CJ, Lin CH, Wen LL (2009) Interleukin-1beta is increased in the cerebrospinal fluid of patients with small infarcts. Eur J Neurol 16:858-863.
34. Switzer J, Sikora A, Ergul A, Waller JL, Hess DC, Fagan SC (2012) Minocycline prevents IL-6 increase after acute ischemic stroke. Transl Stroke Res 3:363-368.
35. Taga T, Kishimoto T (1997) Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol 15:797-819.
36. Tarkowski E, Rosengren L, Blomstrand C, Wikkelso C, Jensen C, Ekholm S, Tarkowski A (1997) Intrathecal release of pro-and anti--inflammatory cytokines Turing stroke. Clin Exp Immunol 110:492-499.
37. Tarkowski E, Rosengren L, Blomstrand Ch et al. (1995) Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke stroke. 26:1393-1398.
38. Tuttolomondo A, Di Raimondo D, di Sciacca R et al. (2008) Inflammatory cytokines in acute ischemic stroke. Curr Pharm Des 14:3574-3589.
39. Waje-Andreassen U, Kråkenes J, Ulvestad E et al. (2005) IL-6:an early marker for outcome in acute ischemic stroke. Acta Neurol Scand 111: 360-365.
40. Whiteley W, Jackson C, Lewis S, Lowe G, Rumley A, Sandercock P, Wardlaw J, Dennis M, Sudlow C (2009) Inflammatory markers and poor outcome after stroke:a prospective cohort study and systematic review of interleukin-6. PLoS Med 6:1-11.
41. Yoon J, Lee J, Tweedie D, Mughal M, Chigurupati S, Greig N, Mattson M (2013) 3,6'-dithiothalidomide improves experimental stroke outcome by suppressing neuroinflammation. J Neurosci Res 91:671-680.
42. Zaremba J, Losy J (2001) Early TNF-alpha levels correlate with ischaemic stroke severity. Acta Neurol Scand 104:288-295.
43. Zaremba J, Skrobanski P, Losy J (2001) Tumour necrosis factor-alpha is increased in the cerebrospinal fluid and serum of ischaemic stroke patients and correlates with the volume of evolving brain infarct. Biomed Pharmacother 55:258-263.
44. Zaremba J, Losy J (2004) Cytokiny w klinicznym i doswiadczalnym udarze niedokrwiennym mózgu. Neurologia i Neurochirurgia Polska 38 (Suppl. 1):57-62 (in Polish).